Verastem, Inc.

VSTMNASDAQUSD
7.45 USD
0.11 (1.55%)🟢PRE MARKET (AS OF 04:01 AM EDT)
🟢Market: OPEN

Verastem, Inc. (VSTM) trades at $7.45 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Sep 15, 2026.

Open?$7.45
High?$7.45
Low?$7.45
Prev. Close?$7.34
Volume?N/A
Avg. Volume?2.2M
Bid / Ask
Bid?$6.42 × 100
Ask?$8.35 × 100
Spread?$1.93
Midpoint?$7.39
Valuation & Ratios
Market Cap?664.7M
Shares Out?90.6M
Float?84.4M
Float %?93.2%
P/E Ratio?N/A
P/B Ratio?13.30
EPS?-$2.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Employees
102
Market Cap
680.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2012-01-27
Address
117 KENDRICK STREET
NEEDHAM, MA 02494
Phone: (781) 292-4200
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
83
Short Sent.?
39
Piotroski F-Score?4/9Mixed
Altman Z-Score?-7.39Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.67%Squeeze Risk
Short Interest?18.3M
Days to Cover?11.0
Free Float84.4M
Avg Daily Volume1.7M
Settlement Date2026-08-31
Financial Health
Current Ratio?2.25Strong
Quick Ratio?2.22Strong
Cash Ratio?1.75Strong
Debt/Equity?1.63High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A
P/B?
Peers
100
S&P
14
13.30HIGH
P/S?
Peers
100
S&P
15
7.59HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.9CHEAP
EV/Sales?
Peers
100
S&P
20
6.97HIGH
Returns & Efficiency
ROE?
S&P
3
-405.5%WEAK
ROA?
S&P
3
-98.2%WEAK
Cash Flow & Enterprise
FCF?$-162195000
Enterprise Value?$610.1M
Fundamentals ratios updated end of day